Total Valuation
Dongsung Pharmaceutical Co., Ltd. has a market cap or net worth of ₩174.28B. The enterprise value is ―.
Market Cap₩174.28B
Enterprise Value―
Share Statistics
Dongsung Pharmaceutical Co., Ltd. has 96,619,510 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding96,619,510
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Dongsung Pharmaceutical Co., Ltd.’s return on equity (ROE) is -1.10 and return on invested capital (ROIC) is -19.94%.
Return on Equity (ROE)-1.10
Return on Assets (ROA)-0.15
Return on Invested Capital (ROIC)-19.94%
Return on Capital Employed (ROCE)-0.59
Revenue Per Employee292.51M
Profits Per Employee-86.37M
Employee Count298
Asset Turnover0.52
Inventory Turnover2.61
Valuation Ratios
The current PE Ratio of Dongsung Pharmaceutical Co., Ltd. is ―. Dongsung Pharmaceutical Co., Ltd.’s PEG ratio is -0.00340.
PE Ratio―
PS Ratio0.26
PB Ratio0.95
Price to Fair Value0.95
Price to FCF-1.57
Price to Operating Cash Flow―
PEG Ratio-0.00340
Income Statement
In the last 12 months, Dongsung Pharmaceutical Co., Ltd. had revenue of 87.17B and earned -25.74B in profits. Earnings per share was -1.13K.
Revenue87.17B
Gross Profit36.36B
Operating Income-22.87B
Pretax Income-28.69B
Net Income-25.74B
EBITDA-20.73B
Earnings Per Share (EPS)-1.13K
Cash Flow
In the last 12 months, operating cash flow was -12.86B and capital expenditures -1.30B, giving a free cash flow of -13.51B billion.
Operating Cash Flow-12.86B
Free Cash Flow-13.51B
Free Cash Flow per Share-139.80
Dividends & Yields
Dongsung Pharmaceutical Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.14
52-Week Price Change77.70%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Dongsung Pharmaceutical Co., Ltd. upcoming earnings date is Aug 18, 2026, TBA (Confirmed).
Last Earnings DateMay 15, 2026
Next Earnings DateAug 18, 2026
Ex-Dividend Date―
Financial Position
Dongsung Pharmaceutical Co., Ltd. as a current ratio of 0.69, with Debt / Equity ratio of ―
Current Ratio0.69
Quick Ratio0.54
Debt to Market Cap2.88
Net Debt to EBITDA-2.91
Interest Coverage Ratio-2.35
Taxes
In the past 12 months, Dongsung Pharmaceutical Co., Ltd. has paid -2.95B in taxes.
Income Tax-2.95B
Effective Tax Rate0.10
Enterprise Valuation
Dongsung Pharmaceutical Co., Ltd. EV to EBITDA ratio is -3.98, with an EV/FCF ratio of -5.83.
EV to Sales0.95
EV to EBITDA-3.98
EV to Free Cash Flow-5.83
EV to Operating Cash Flow-6.42
Balance Sheet
Dongsung Pharmaceutical Co., Ltd. has ₩3.86B in cash and marketable securities with ₩64.13B in debt, giving a net cash position of -₩60.27B billion.
Cash & Marketable Securities₩3.86B
Total Debt₩64.13B
Net Cash-₩60.27B
Net Cash Per Share-₩623.81
Tangible Book Value Per Share₩1.00K
Margins
Gross margin is ―, with operating margin of -26.23%, and net profit margin of -29.53%.
Gross Margin―
Operating Margin-26.23%
Pretax Margin-32.91%
Net Profit Margin-29.53%
EBITDA Margin-23.78%
EBIT Margin-26.23%
Analyst Forecast
The average price target for Dongsung Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-13.18%
EPS Growth Forecast-46.96%